Welltower Inc. (NYSE:HCN) is expected to pay $0.86 on Nov 21, 2016. The indicated annual dividend is $3.44. Shareholders owning the stock before Nov 4, 2016 will be eligible to receive the payout. Based on Welltower Inc.’s current price of $67.21, the dividend is 1.28%. This dividend’s record date is Nov 8, 2016 and the announcement date is Oct 28, 2016. The stock closed at $67.21 during the last session. It is down 2.82% since April 1, 2016 and is downtrending. It has underperformed by 4.03% the S&P500.
Welltower Inc., formerly Health Care REIT, Inc., is a well-known provider of healthcare infrastructure. The company has a market cap of $23.98 billion. The Firm operates through three divisions: triple-net, which includes independent living facilities, independent supportive living facilities , continuing care retirement communities, assisted living facilities, care homes with and without nursing (United Kingdom), Alzheimer’s/dementia care facilities, long-term/post-acute care facilities and hospitals; seniors housing operating, which includes a range of facility types, including independent living facilities and independent supportive living facilities, assisted living facilities, care homes and Alzheimer’s/dementia care facilities, and outpatient medical, which includes outpatient medical buildings. It has a 38.31 P/E ratio. It invests in seniors housing operators, post-acute providers and health systems to fund real estate and infrastructure.
Insitutional Activity: The institutional sentiment decreased to 0.5 in Q2 2016. Its down 0.35, from 0.85 in 2016Q1. The ratio turned negative, as 4 funds sold all Welltower Inc shares owned while 6 reduced positions. 0 funds bought stakes while 5 increased positions. They now own 169,883 shares or 26.93% less from 232,502 shares in 2016Q1.
Budros Ruhlin & Roe Incorporated last reported 0.34% of its portfolio in the stock. Eqis Capital Mngmt Inc last reported 11,622 shares in the company. Invest Advisors Lc holds 0.28% of its portfolio in Welltower Inc (NYSE:HCN) for 39,299 shares. The Virginia-based Pettyjohn Wood And White has invested 0.3% in Welltower Inc (NYSE:HCN). Wendell David Assocs, a New Hampshire-based fund reported 19,200 shares. The Massachusetts-based American Mngmt has invested 0.2% in Welltower Inc (NYSE:HCN). Ironwood Investment Counsel Ltd Company reported 5,908 shares or 0.12% of all its holdings. Liberty Capital Mngmt has invested 0.88% of its portfolio in Welltower Inc (NYSE:HCN). Gemmer Asset Ltd holds 164 shares or 0.01% of its portfolio. Alphamark Advsrs Limited Liability Co holds 11,302 shares or 0.51% of its portfolio. Focused Wealth Management Inc has invested 0.29% of its portfolio in Welltower Inc (NYSE:HCN). Huntington National Bank & Trust has 22,623 shares for 0.04% of their US portfolio. Moreover, A D Beadell Inv Counsel Incorporated has 0.26% invested in Welltower Inc (NYSE:HCN) for 4,150 shares.
Insider Transactions: Since May 17, 2016, the stock had 0 insider purchases, and 7 sales for $5.30 million net activity. ESTES SCOTT A also sold $243,956 worth of Welltower Inc (NYSE:HCN) shares. IBELE ERIN C sold $180,242 worth of stock or 2,500 shares. $1.93 million worth of shares were sold by Miller Jeffrey H on Wednesday, September 7. Brinker Scott M also sold $1.41 million worth of Welltower Inc (NYSE:HCN) shares.
Welltower Inc (NYSE:HCN) Ratings Coverage
Out of 15 analysts covering Health Care Reit Inc. (NYSE:HCN), 5 rate it a “Buy”, 1 “Sell”, while 9 “Hold”. This means 33% are positive. $86 is the highest target while $57 is the lowest. The $72.67 average target is 8.12% above today’s ($67.21) stock price. Health Care Reit Inc. has been the topic of 28 analyst reports since July 21, 2015 according to StockzIntelligence Inc. The stock of Welltower Inc (NYSE:HCN) earned “Buy” rating by Canaccord Genuity on Tuesday, August 4. The rating was maintained by Evercore with “Buy” on Tuesday, September 8. BTIG Research initiated Welltower Inc (NYSE:HCN) on Thursday, August 25 with “Neutral” rating. UBS maintained the shares of HCN in a report on Tuesday, August 23 with “Neutral” rating. BMO Capital Markets downgraded the stock to “Underperform” rating in Wednesday, January 27 report. The firm has “Outperform” rating by RBC Capital Markets given on Monday, February 22. The firm has “Buy” rating by Canaccord Genuity given on Monday, August 15. Mizuho maintained Welltower Inc (NYSE:HCN) on Friday, February 19 with “Neutral” rating. JP Morgan downgraded the stock to “Neutral” rating in Thursday, December 17 report. The stock has “Outperform” rating given by RBC Capital Markets on Tuesday, January 26.
More notable recent Welltower Inc (NYSE:HCN) news were published by: Fool.com which released: “Welltower Inc.’s Earnings Rise on New Additions” on November 02, 2016, also Businesswire.com with their article: “Welltower Inc. Declares Third Quarter 2016 Dividend” published on October 27, 2016, Forbes.com published: “Ex-Dividend Reminder: Welltower, TD Ameritrade Holding and Carlyle Group” on November 02, 2016. More interesting news about Welltower Inc (NYSE:HCN) were released by: Fool.com and their article: “Better Buy: Welltower Inc. vs. Brookdale Senior Living” published on October 15, 2016 as well as Globenewswire.com‘s news article titled: “Genesis HealthCare Announces New Leases for 92 Facilities Historically Leased …” with publication date: November 02, 2016.
HCN Company Profile
Welltower Inc., formerly Health Care REIT, Inc., incorporated on April 4, 1985, is a well-known provider of healthcare infrastructure. The Firm operates through three divisions: triple-net, seniors housing operating and outpatient medical. The Firm invests in seniors housing operators, post-acute providers and health systems to fund real estate and infrastructure. Welltower, a real estate investment trust (REIT), owns properties in the United States, Canada and the United Kingdom, consisting of seniors housing and post-acute communities and outpatient medical properties.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.